Showing results (491-500 of 528) with videos related to
Sort By:
Pageof 53
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Novel breast tissue feature strongly associated with risk of breast cancerKevin P McKian, Carol A Reynolds, Daniel W Visscher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Stratification of breast cancer risk in women with atypia: a Mayo cohort studyAmy C Degnim, Daniel W Visscher, Hal K Berman, et al.BMC Cancer|February 2, 2017
Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohortRobert A Vierkant, Amy C Degnim, Derek C Radisky, et al.The New England Journal of Medicine|July 22, 2005
Benign breast disease and the risk of breast cancerLynn C Hartmann, Thomas A Sellers, Marlene H Frost, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 21, 2018
Model for Predicting Breast Cancer Risk in Women With Atypical HyperplasiaAmy C Degnim, Stacey J Winham, Ryan D Frank, et al.Cancer Research|November 16, 2014
Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancerEvanthia Galanis, Pamela J Atherton, Matthew J Maurer, et al.Cancer|October 30, 2015
Clinicopathologic features of breast cancers that develop in women with previous benign breast diseaseDaniel W Visscher, Marlene H Frost, Lynn C Hartmann, et al.Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.Cancer Research|April 15, 2014
Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancerChen Wang, Mine S Cicek, Bridget Charbonneau, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2011
Expression of p16 and retinoblastoma determines response to CDK4/6 inhibition in ovarian cancerGottfried E Konecny, Boris Winterhoff, Teodora Kolarova, et al.Pageof 53